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Summary It seems that migraine patients might suffer from localized and not systemic
endothelial dysfunction. However, the probability whether impaired endothelial function in
the posterior cerebral circulation, and intact endothelial function elsewhere is associated with
migraine is not known. This is a post hoc study based on two of our previous published stud-
ies that evaluated cerebral and systemic endothelial function in 40 migraine patients (20 with
(MwA) and 20 without aura (MwoA)) without comorbidities, and 20 healthy subjects. Cere-
brovascular reactivity (CVR) to L-arginine in the middle (MCA) and posterior (PCA) cerebral
artery as well as ﬂow mediated vasodilatation (FMD) were used for this purpose. The logistic
regression analysis was used to evaluate the association between CVR to L-arginine, FMD and
migraine. We found a signiﬁcant association between CVR to L-arginine in the PCA and migraine
(OR: 0.38; CI 95%: 0.19—0.79; p = 0.01), but not between CVR to L-arginine in the MCA and
migraine (OR: 0.74; CI 95%: 0.34—1.59; p = 0.44). Similar results were obtained in MwA and
MwoA. We did not ﬁnd any signiﬁcant association between FMD and migraine (OR: 0.99; CI 95%:
0.83—1.19; p = 0.96). The same conclusion was reached in both migraine groups (MwA OR: 1.0; CI
95%: 0.83—1.19; p = 0.99, MwoA OR: 0.99; CI 95%: 0.81—1.21; p = 0.99). We could conclude that
impaired endothelial function in the posterior cerebral circulation is associated with migraine,
both MwA and MwoA, while intact endothelial function in the anterior cerebral and systemic
circulation is not associated only with migraine.
t
 access© 2012 Elsevier GmbH.
Introduction
OpenThere is some evidence that migraine patients might have
endothelial dysfunction [1]. In this context, it is proposed
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Open access under CC BY-NC-ND license.hat migraine could lead to endothelial dysfunction or
ndothelial dysfunction could lead to migraine [1]. Never-
heless, endothelial dysfunction could be important in the
athophysiology of vascular diseases in migraine patients.
amely, several studies have shown that migraine is asso-
 under CC BY-NC-ND license.iated with disorders of the cerebrovascular, coronary,
etinal and peripheral vasculatures [1]. However, it must
e emphasized that in many studies the authors did not
xclude vascular risk factors, or perhaps, besides excluding
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any vascular risk factors, they did not evaluate carotid
ntima—media thickness (IMT), a morphological marker of
he early atherosclerotic process [2—7]. Therefore, all the
lready mentioned vascular disorders in migraine patients
ight be a consequence of vascular risk factors, or of an
nrecognized atherosclerotic process.
Despite this fact, it was still unclear whether endothelial
ysfunction in migraine patients could be isolated or sys-
emic. In accordance with that, we have conducted two
tudies to assess whether migraine patients have systemic
r just isolated cerebral endothelial dysfunction [8,9]. The
ethods of cerebrovascular reactivity (CVR) to L-arginine
nd ﬂow-mediated vasodilatation (FMD) were used to assess
he anterior and posterior cerebral and systemic endothelial
unction [10—17]. We also measured carotid IMT, gath-
red medical history, performed physical and neurological
xaminations, as well as ran clinical laboratory tests. Only
igraine patients without comorbidities and with normal
MT were included.
In our ﬁrst study we have shown that migraine patients
ithout comorbidities, both with or without aura, might
ave intact systemic endothelial function [8].
In our second study we have found reduced vasodilata-
ory capacity in the territory of the posterior cerebral
rtery (PCA), and intact in the territory of the middle cere-
ral artery (MCA) which could indicate impaired cerebral
ndothelial function in the posterior cerebral circulation in
igraine patients without comorbidities [9].
The aim of this post hoc study was to evaluate whether
mpaired endothelial function of the posterior cerebral
irculation and intact endothelial function of the ante-
ior cerebral and systemic circulation are associated with
igraine. These comparisons have not yet been performed.
aterials and methods
his post hoc study was performed using data obtained
rom our two previous studies, which were approved by the
ational Medical Ethics Committee of the Republic of Slove-
ia. Forty migraine patients and twenty healthy subjects
articipated. All subjects gave written informed consent
efore being included in the study. Migraine patients were
iagnosed according to the International Headache Society
riteria (2nd edition) [18]. Healthy subjects were randomly
elected from hospital staff and acquaintances after com-
leting a questionnaire. Migraine patients were randomly
elected from a headache clinic. All subjects had a normal
omatic and neurological examination. Migraine patients
ere divided into two groups, 20 patients with migraine
ith aura (MwA), and 20 patients without aura (MwoA). The
hree groups were matched for gender and age. None of the
ubjects in the control group were suffering from headache
hen the study was conducted, and none had migraine or
ther headache. Migraine patients had the last migraine
pisode more than 24 h before the investigations were con-
ucted.
The major exclusion criteria were: history ofardiovascular disease, arterial hypertension (sys-
olic blood pressure (SBP) > 140mmHg or diastolic
lood pressure (DBP) > 90mmHg), body mass index
BMI) < 18 and ≥25 kg/m2, hypercholesterolemia (total
d
M
M
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holesterol > 5.5mmol/L), diabetes, IMT > 1.0mm, preg-
ancy or lactation and regular use of vasoactive drugs
except triptane, or other transient vasoactive antimigraine
rugs). Therefore, all subjects had normal values of SBP,
BP, BMI, total cholesterol, HDL, LDL, triglycerides, IMT,
nd glucose [8,9].
Color-coded duplex sonography of the carotid and ver-
ebral arteries was performed with all patients. IMT was
easured according to the Mannheim Intima—Media Thick-
ess Consensus on both sides 2 cm below the bifurcation on
he far wall of the common carotid artery [19]. The distance
etween the characteristic echoes from the lumen—intima
nd media—adventitia interfaces was measured. The ﬁnal
MT value was based on the mean value of three maximal
MT measurements. Subjects with plaques (focal structures
hat encroached into the arterial lumen of at least 0.5mm
r 50% of the surrounding IMT value or demonstrated a thick-
ess > 1.5mm) were excluded from the study.
FMD of the right brachial artery was performed accord-
ng to the recommendations of Corretti et al. in a quiet
oom under constant conditions between 7.30 and 10.30
m after a fasting period of at least 10 h [20]. A high-
esolution ultrasound system with a 10-MHz linear array
ransducer located 2—10 cm above the antecubital fossa
as used. The brachial artery was scanned in the longitu-
inal section, and the end-diastolic mean arterial diameter
as measured at the end of the diastole period, incident
ith the R-wave on the simultaneously recorded electrocar-
iogram. A hyperemic ﬂow increase was then induced by
nﬂation of a blood pressure cuff to a pressure of 50mm Hg
igher than the measured systolic blood pressure for 4min.
he hyperemic diameter was recorded within 1min after
uff deﬂation, and the ﬁnal scan was performed 4min later.
MD was expressed as the percentage change in the artery
iameter after reactive hyperemia relative to the baseline
can.
CVR to L-arginine was simultaneously measured in the
nterior and posterior cerebral circulation. For this pur-
ose, the middle (MCA) and the posterior cerebral artery
PCA) were chosen. The experiment consisted of a 10-min
aseline period, a 30-min intravenous infusion of 100mL 30%
-arginine, and a 10-min period after L-arginine application.
he mean arterial velocity (vm) in the MCA was recorded
hrough the left temporal acoustic window at a depth of
0—60mm, and in the PCA through the right temporal acous-
ic window at a depth of 50—60mm,with amechanical probe
older maintaining a constant probe position. TCD Multi-Dop
4 software was used to determine vm during the 5-min base-
ine period and the 5-min period after L-arginine infusion.
VR to L-arginine in the PCA and the MCA was expressed
s the percentage change in the vm after stimulation with
-arginine.
The variables FMD, CVR, migraine and healthy subjects
ere statistically analyzed by the statistic software SPSS
8.0. For this purpose, binary logistic regression analysis was
sed to analyze a possible association between FMD, CVR
nd migraine. The dependent variable was the presence of
igraine (yes = 1, no = 0). In a further analysis, the depen-
ent variable was the presence of migraine type (MwA= 1,
woA = 0). Independent variables CVR to L-arginine in the
CA, CVR to L-arginine in the PCA and FMD were transformed
nto attributive variables.
Cerebral and systemic circulation in migraine
Table 1 The association of cerebrovascular reactivity
(CVR) to L-arginine in the posterior cerebral artery (PCA) and
in the middle cerebral artery (MCA) with migraine.
B P Exp (B) or OR CI 95%
CVR PCA −0.95 0.01 0.38 0.19—0.79
CVR MCA −0.29 0.44 0.74 0.34—1.59
Table 2 The association of CVR to L-arginine in the PCA and
the MCA with migraine with (MwA) and without aura (MwoA).
B P Exp (B) or OR CI 95%
CVR PCA MwA −0.93 0.01 0.39 0.19—0.80
CVR PCA MwoA −1.01 0.02 0.36 0.15—0.86
CVR MCA MwA −0.33 0.39 0.71 0.33—1.54
CVR MCA MwoA −0.34 0.47 0.71 0.27—1.83
Table 3 The association of ﬂow mediated dilatation (FMD)
with migraine, and separately with migraine with (MwA) and
without aura (MwoA).
B P Exp (B) or OR CI 95%
FMD −0.00 0.96 0.99 0.83—1.19
FMD MwA 0.00 0.99 1.00 0.83—1.19
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Results
In step one, we evaluated a possible association of CVR to
L-arginine in the MCA and the PCA with migraine, and also
of CVR to L-arginine in the MCA and the PCA with MwA and
MwoA.
We found a signiﬁcant negative association between
CVR to L-arginine in the PCA and migraine (p = 0.01), but
not between CVR to L-arginine in the MCA and migraine
(p = 0.44). The results are summarized in Table 1.
Similarly, we found a signiﬁcant negative association
between CVR to L-arginine in the PCA on MwA (p = 0.01) and
between CVR to L-arginine in the PCA and MwoA (p = 0.02).
Again we did not ﬁnd any association between CVR to L-
arginine in the MCA and MwA (p = 0.39) and also between
CVR to L-arginine and MwoA (p = 0.47). The results are sum-
marized in Table 2.
In step two, we evaluated a possible association of FMD
with migraine, and repeated the procedure separately with
MwA and MwoA. The results are represented in Table 3.
The binary logistic regression did not show any association
between FMD and migraine (p = 0.96) and also between FMD
and MwA (p = 0.99) and MwoA (p = 0.99).Discussion
The main original ﬁnding of our post hoc study is that we
have found a signiﬁcant negative association between CVR to
f
w
r
w299
-arginine in the posterior cerebral circulation and migraine,
nd no association between CVR to L-arginine in the anterior
erebral circulation and migraine.
In recent years it has been proposed that migraine affects
ot only systemic but also cerebral circulation [1]. Namely,
schemic stroke can occur between or during migraine
ttacks, particularly in MwA and young women [21—24]. The
erritory of the posterior cerebral artery is preferentially
ffected [25]. In addition to clinical strokes, focal ischemic
nd hyperintensive, ischemic-like lesions have been found in
he territory of the posterior cerebral circulation [22,26,27].
n our previous study we showed a lower CVR to L-arginine in
he PCA and normal CVR to L-arginine in the MCA in migraine
atients without comorbidities compared to healthy sub-
ects [9]. In such circumstances this could be applied to
erebral endothelial dysfunction localized only in the ter-
itory of the posterior cerebral circulation. However, a
onﬁrmation from another point of view was still miss-
ng. For this purpose we analyzed the association between
igraine and parameters of systemic, as well as cerebral
ndothelial function. The ﬁndings of this study have shown
hat impaired posterior cerebral endothelial function could
e associated with migraine, while intact anterior cere-
ral endothelial function could not be only associated with
igraine but it could be also attributed to physiological con-
itions.
The other main ﬁnding of our study is that we did not
nd any association between CVR to L-arginine in the MCA,
MD and migraine. In other words, our study showed that
ntact endothelial function in the anterior cerebral and sys-
emic circulation could not be only associated with migraine
ut again this could be also attributed to physiological
onditions. This again is in accordance with one of our
revious ﬁndings that migraine patients without comorbidi-
ies and early atherosclerotic process probably have intact
ystemic endothelial function [8]. This has also been sug-
ested by Vanmolkot and de Hoon [28]. In recent years it
as been proposed that migraine is associated with dis-
rders of the coronary, retinal and peripheral vasculature
1]. However, in many studies the authors did not exclude
ascular risk factors, or perhaps they excluded many vascu-
ar risk factors, but did not evaluate IMT, a morphological
arker of the early atherosclerotic process and associated
ndothelial dysfunction, which consequently might have
iased their ﬁndings [2—7]. Therefore, according to the pre-
ious sentence, the ﬁndings of our current and previous
tudies might suggest that behind vascular disorders could
ot be systemic endothelial dysfunction but perhaps local-
zed endothelial dysfunction or other pathological vascular
onditions.
onclusion
aking into account all the presented ﬁndings of this and pre-
ious studies, the following can be concluded in migraine
atients without comorbidities: (I) impaired endothelial
unction in the posterior cerebral circulation is associated
ith migraine; (II) intact endothelial function in the ante-
ior cerebral and systemic circulation is not associated only
ith migraine.
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